SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Mish's Global Economic Trend Analysis

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim McMannis who wrote (40243)10/31/2005 6:48:50 PM
From: Bucky Katt  Read Replies (1) of 116555
 
Countries seek to bypass Tamiflu patent

Tamiflu is considered one of the few drugs likely to be effective against the spread of bird flu among humans

India and two other countries have indicated they may authorise generic production of flu drug Tamiflu without the prior approval of the Swiss producer, Roche.

It comes amid growing fears of a bird-flu pandemic. Under World Trade Organisation rules, countries facing a public health emergency can issue licences to legally manufacture generic versions of patented drugs.

More>http://www.siliconinvestor.com/readmsg.aspx?msgid=21826592
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext